Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BELLOSA, NORA

NPI: 1982763421 · OAK LAWN, IL 60453 · Pediatric Adolescent Medicine Physician · NPI assigned 12/08/2006

$294K
Total Medicaid Paid
6,275
Total Claims
5,059
Beneficiaries
24
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 648 $32K
2019 1,041 $46K
2020 749 $31K
2021 1,038 $47K
2022 1,218 $62K
2023 772 $40K
2024 809 $36K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,126 1,668 $103K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,346 1,110 $102K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 330 294 $21K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 192 165 $14K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 142 88 $11K
96127 327 181 $8K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 156 132 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 361 287 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 129 103 $4K
99401 155 145 $4K
87428 62 57 $4K
90686 417 376 $4K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 127 100 $3K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 33 25 $3K
90656 68 62 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 18 17 $635.94
87807 35 31 $352.10
90670 25 25 $153.60
99406 38 30 $97.50
99072 44 42 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 30 25 $0.00
87081 65 56 $0.00
1036F 33 28 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 16 12 $0.00